logo
Study uncovers alarming prevalence of disease linked to stillbirths: 'Will become even more widespread in the future'

Study uncovers alarming prevalence of disease linked to stillbirths: 'Will become even more widespread in the future'

Yahoo13-05-2025
A new study has revealed that Oropouche virus may be more prevalent in Latin America than initially believed — and it may be negatively impacting a vulnerable population.
Oropouche virus is a vector-borne disease, which means that a living organism is what passes it on to humans. In this case, mosquitoes and biting midges (a kind of fly) are the vectors that transmit Oropouche.
According to The Telegraph, Oropouche virus was found outside of its endemic area of Brazil for the first time in October 2023. While the World Health Organization says it was also detected in Trinidad and Tobago in 1955, it has spread "rapidly" to other South American and Caribbean countries since the 2023 discovery, per the report.
In fact, a study published in The Lancet Infectious Diseases suggests that Oropouche's stint in those regions may have started as early as 2001.
Researchers analyzed 9,400 blood samples from 2001 to 2022 from patients in Bolivia, Colombia, Costa Rica, Ecuador, and Peru. They found that 6.3% of individuals had Oropouche antibodies, indicating they were previously infected with Oropouche virus.
While there is still a lot that researchers don't know about Oropouche virus, The Telegraph says it has been linked to stillbirths and birth defects. Pregnant people and their children are the most vulnerable to this disease.
The study also found that the El Niño phenomenon accelerates Oropouche transmission. El Niño creates warmer and wetter weather, and Earth's warming climate — driven by human activities, mostly the burning of dirty fuels — has amplified this phenomenon over time.
This weather allows mosquitoes and biting midges to thrive and infect more people, which spells health and environmental problems.
"I think it's possible that Oropouche virus will become even more widespread in the future as climate change progresses," Dr. Jan Drexler, the head of the Virus Epidemiology Laboratory at the Institute of Virology at Charité and lead author of the study, told The Telegraph.
Stopping the transmission of Oropouche virus can help keep global communities safe. Taking action to protect the environment can be one of the best ways to do this.
Do you worry about getting diseases from bug bites?
Absolutely
Only when I'm camping or hiking
Not really
Never
Click your choice to see results and speak your mind.
Individuals can help by reducing their heat-trapping pollution through adopting energy-efficient appliances, taking public transportation, and installing solar panels, among other things.
There is no treatment for Oropouche virus, so the best way to protect yourself is to be preventative.
There are many ways to protect yourself from Oropouche virus and other diseases, such as Zika and West Nile, that are transmitted by mosquitoes. The WHO recommends using mesh bed nets, chemical insecticides, protective clothing, and insect repellents.
The authors of the study also recommend that health care workers in the Americas familiarize themselves with the signs and symptoms of Oropouche virus, per The Telegraph. These include fever, headaches, and muscle pain.
The symptoms may overlap with those of other illnesses such as dengue fever, as the WHO explains, but knowing that Oropouche is an option may help with diagnoses and treatments.
Join our free newsletter for weekly updates on the latest innovations improving our lives and shaping our future, and don't miss this cool list of easy ways to help yourself while helping the planet.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Southern China hit by outbreak of mosquito-borne infection chikungunya
Southern China hit by outbreak of mosquito-borne infection chikungunya

San Francisco Chronicle​

time5 hours ago

  • San Francisco Chronicle​

Southern China hit by outbreak of mosquito-borne infection chikungunya

China is experiencing an outbreak of chikungunya, a mosquito-borne infection, with thousands of cases reported in the south. Chikungunya fever cases jumped to 4,014 on Friday, representing a rapid rise in numbers since authorities started tracking cases two weeks ago, according to public records released by health departments in districts in Foshan. The city in China's southern province Guangdong has been heavily impacted by the surge in infections. The chikungunya outbreak remains 'quite severe,' Sun Yang, deputy director of the National Center for Disease Control and Prevention, said at a news conference on Wednesday in Foshan. Chikungunya is spread to people by the bites of infected mosquitoes. It causes fever and severe joint pain, but deaths are rare, according to the World Health Organization. The Chinese Center for Disease Control and Prevention has issued various advisories on how to prevent chikungunya fever and dengue fever, a similar disease also spread by mosquitoes. Physical protection barriers, such as screen doors, mosquito nets for beds and mosquito repellent on exposed skin, was recommended. It said that the epidemic was 'imported' without specifying from where. The Chinese agency also called for people who have symptoms like fever, rash and joint pain to see a doctor. Shunde district in Foshan, where 90% of the cases are located, is famous for its Cantonese food, and sees many visitors each year. Patients who tested positive for chikungunya fever stayed in hospital beds covered by mosquito nets, according to photos shown on state-run broadcaster CCTV. Local media reports said on Thursday that local authorities had almost doubled the number of mosquito-proof isolation beds to 7,220 to meet the growing demand. Authorities in Guangdong are urging residents to make sure there's no standing water in their homes, such as in flowerpots, coffee machines or spare bottles. The Health Commission in Foshan stated on Thursday that a fine of up to 10,000 yuan ($1,400) could be applied if violations are found. The Beijing CDC said on Tuesday that the city occasionally experiences imported cases of chikungunya fever. There are two chikungunya vaccines that have received regulatory approvals in several countries and/or have been recommended for use in populations at risk, but the vaccines are neither widely available nor in widespread use, according to WHO.

Southern China hit by outbreak of mosquito-borne infection chikungunya
Southern China hit by outbreak of mosquito-borne infection chikungunya

Hamilton Spectator

time5 hours ago

  • Hamilton Spectator

Southern China hit by outbreak of mosquito-borne infection chikungunya

China is experiencing an outbreak of chikungunya, a mosquito-borne infection, with thousands of cases reported in the south. Chikungunya fever cases jumped to 4,014 on Friday, representing a rapid rise in numbers since authorities started tracking cases two weeks ago, according to public records released by health departments in districts in Foshan. The city in China's southern province Guangdong has been heavily impacted by the surge in infections. The chikungunya outbreak remains 'quite severe,' Sun Yang, deputy director of the National Center for Disease Control and Prevention, said at a news conference on Wednesday in Foshan. Chikungunya is spread to people by the bites of infected mosquitoes. It causes fever and severe joint pain, but deaths are rare, according to the World Health Organization. The Chinese Center for Disease Control and Prevention has issued various advisories on how to prevent chikungunya fever and dengue fever, a similar disease also spread by mosquitoes. Physical protection barriers, such as screen doors, mosquito nets for beds and mosquito repellent on exposed skin, was recommended. It said that the epidemic was 'imported' without specifying from where. The Chinese agency also called for people who have symptoms like fever, rash and joint pain to see a doctor. Shunde district in Foshan, where 90% of the cases are located, is famous for its Cantonese food, and sees many visitors each year. Patients who tested positive for chikungunya fever stayed in hospital beds covered by mosquito nets, according to photos shown on state-run broadcaster CCTV. Local media reports said on Thursday that local authorities had almost doubled the number of mosquito-proof isolation beds to 7,220 to meet the growing demand. Authorities in Guangdong are urging residents to make sure there's no standing water in their homes, such as in flowerpots, coffee machines or spare bottles. The Health Commission in Foshan stated on Thursday that a fine of up to 10,000 yuan ($1,400) could be applied if violations are found. The Beijing CDC said on Tuesday that the city occasionally experiences imported cases of chikungunya fever. There are two chikungunya vaccines that have received regulatory approvals in several countries and/or have been recommended for use in populations at risk, but the vaccines are neither widely available nor in widespread use, according to WHO. China had its first chikungunya spike in 2010 with 253 cases in Dongguan, a nearby city in the same province, according to the Guangdong provincial CDC. Several cases were found in years since then, but they weren't widespread. The country's first case was imported in 1987, according to research papers and media reports.

Next-Gen Breakthroughs Transform Influenza Diagnostics
Next-Gen Breakthroughs Transform Influenza Diagnostics

Time Business News

time6 hours ago

  • Time Business News

Next-Gen Breakthroughs Transform Influenza Diagnostics

Influenza diagnostics refers to methods and devices that are used to detect influenza virus infections in individuals, including rapid antigen tests, molecular assays (such as RT-PCR), and immunoassays. The market for influenza diagnostics is increasing due to increasing global awareness about infectious diseases, increasing incidence of influenza and increasing outbreaks, increasing demand for rapid and accurate testing, increasing demand for progress in clinical technologies and further emphasis on the identity of initial diseases and the identity of early diseases by governments and healthcare organizations. Key Growth Drivers and Opportunities Global Awareness about Infectious Diseases: Global awareness about infectious diseases increases the demand for increasing, accurate, accurate and comprehensive testing. Recent experiences with epidemic such as public health campaigns, media coverage, and Covid-19 have increased the importance of the general population of viral transmission and timely diagnosis. As a result, the healthcare provider and the government are prioritizing investment in clinical infrastructure, rapid testing development and monitoring systems to prevent large -scale outbreaks. This awareness leads to maximum adoption of influenza diagnostic tools in hospitals, clinics, airports and even home settings, which promotes continuous market growth. Challenges Influenza diagnostics faces the high cost of advanced testing technologies in the market, low income and clinical equipment limited to clinical equipment in rural areas and the limits of variability in test accuracy-especially with antigen tests that may be false negative. Additionally, the seasonal nature of influenza may demand ups and downs, affecting continuous revenue creation and investment. Regulatory obstacles and skilled personnel need to be widely adopted to adopt molecular diagnosis. Innovation and Expansion Quest Diagnostics Gets CDC Contracts to Create Oropouche Virus and H5 Avian Flu Tests In October 2024, leading diagnostic information services provider Quest Diagnostics announced that the U.S. Centers for Disease Control and Prevention (CDC) has awarded it multiple contracts to support testing and ongoing laboratory readiness for two newly discovered infectious diseases in the Americas. By guaranteeing that a national commercial laboratory provider may promptly augment public health laboratories in the case of an infectious disease epidemic in humans, the agreements will enhance the country's readiness for avian influenza and Oropouche viruses. The FDA Approves the First Over-the-Counter Flu and COVID-19 Test at Home In February 2023, the first over-the-counter (OTC) at-home diagnostic test that can distinguish and identify influenza A and B, sometimes referred to as the flu, and SARS-CoV-2, the virus that causes COVID-19, was granted an emergency use authorization (EUA) by the U.S. Food and Drug Administration. A single-use at-home test kit, the Lucira COVID-19 & Flu Home Test yields findings from self-collected nose swab samples in around half an hour. A single-use test for those exhibiting symptoms and indicators typical of a respiratory tract infection, including COVID-19, is the Lucira COVID-19 & Flu Home Test. The test is available without a prescription and may be done entirely at home with nose swab samples that people 14 years of age or older self-collect. Inventive Sparks, Expanding Markets Investing in major development strategies for influenza diagnostics manufacturers, investing rapidly and in multiplex test technologies, expanding at home and point-of-care test offerings, forming partnership with healthcare providers and governments, securing regulatory approval quickly and strengthening the global distribution network-in special emergence markets. About Author: Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. TIME BUSINESS NEWS

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store